Last $73.74 USD
Change Today -0.11 / -0.15%
Volume 2.3M
ITMN On Other Exchanges
As of 4:30 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel G. Welch

Chairman, Chief Executive Officer and President, InterMune, Inc.
AgeTotal Calculated CompensationThis person is connected to 76 board members in 5 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Daniel G. Welch, also known as Dan, has been the Chairman of InterMune, Inc., since May 13, 2008 and as its Chief Executive Officer and President since September 25, 2003. From March 2003 to September 2003, Mr. Welch served as a Consultant to Warburg Pincus LLC. He served as the Chairman and Chief Executive Officer at Triangle Pharmaceuticals, Inc., from August 2002 to January 2003. Prior to joining Triangle, he served as the President of the Biopharmaceuticals division ...

Read Full Background

Corporate Headquarters*

3280 Bayshore Boulevard
Brisbane, California 94005

United States

Phone: 415-466-2200
Fax: 415-466-2300

Board Members Memberships*

Former Chairman and Chief Executive Officer
Chairman, Chief Executive Officer and President
Director and Member of Compensation Committee
Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Director and Chairman of Nominating & Corporate Governance Committee


University of Miami
University of Miami
University of Miami
University of North Carolina

Other Affiliations*

Annual Compensation*

Total Annual Compensation$703,424

Stock Options*

Restricted Stock Awards$349,650
All Other Compensation$89,754
Exercised Options50,000
Exercised Options Value$335,500
Exercisable Options552,535
Exercisable Options Value$2,210,438
Unexercisable Options287,084
Unexercisable Options Value$1,216,163
Total Value of Options$3,762,100
Total Number of Options889,619

Total Compensation*

Total Annual Cash Compensation$1,420,984
Total Short Term Compensation$703,424
Other Long Term Compensation$439,404
Total Calculated Compensation$2,922,004
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITMN:US $73.74 USD -0.11


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
David T. Hung M.D.Founder, Chief Executive Officer, President and Executive Director
Medivation, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMUNE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at